132 related articles for article (PubMed ID: 1707023)
21. Complementation of expression of carcinoembryonic antigen and tumor associated glycoprotein-72 (TAG-72) in human colon adenocarcinomas.
Simpson JF; Primus FJ; Schlom J
Int J Biol Markers; 1991; 6(2):83-90. PubMed ID: 1716293
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibody recognizing a carcinoembryonic antigen epitope differentially expressed in human colonic carcinoma versus normal adult colon tissues.
Zhang HZ; Ordonez NG; Batsakis JG; Chan JC
Cancer Res; 1989 Oct; 49(20):5766-73. PubMed ID: 2477148
[TBL] [Abstract][Full Text] [Related]
23. Distinguishing malignant mesothelioma from pulmonary adenocarcinoma: an immuno-histochemical approach using a panel of monoclonal antibodies.
Tuttle SE; Lucas JG; Bucci DM; Schlom J; Primus J
J Surg Oncol; 1990 Oct; 45(2):72-8. PubMed ID: 2214794
[TBL] [Abstract][Full Text] [Related]
24. Distinction of mesothelioma from adenocarcinoma. An immunohistochemical approach.
Battifora H; Kopinski MI
Cancer; 1985 Apr; 55(8):1679-85. PubMed ID: 2579718
[TBL] [Abstract][Full Text] [Related]
25. Serum human epididymal protein 4 (HE4) as biomarker for the differentiation between epithelial ovarian cancer and ovarian metastases of gastrointestinal origin.
Stiekema A; Boldingh QJ; Korse CM; van der Noort V; Boot H; van Driel WJ; Kenter GG; Lok CA
Gynecol Oncol; 2015 Mar; 136(3):562-6. PubMed ID: 25560808
[TBL] [Abstract][Full Text] [Related]
26. Binding of five monoclonal anti-CEA antibodies with different epitope specificities to various carcinoma tissues.
Wagener C; Petzold P; Köhler W; Totović V
Int J Cancer; 1984 Apr; 33(4):469-75. PubMed ID: 6200447
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal antibody to a human pancreatic carcinoma cell line recognizes gastrointestinal neoplasms.
Kahn HJ; Yeger H; Loftus R; Goldrosen MH
Am J Pathol; 1989 Mar; 134(3):641-9. PubMed ID: 2466406
[TBL] [Abstract][Full Text] [Related]
28. Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary.
Tornos C; Soslow R; Chen S; Akram M; Hummer AJ; Abu-Rustum N; Norton L; Tan LK
Am J Surg Pathol; 2005 Nov; 29(11):1482-9. PubMed ID: 16224215
[TBL] [Abstract][Full Text] [Related]
29. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.
Molinolo A; Simpson JF; Thor A; Schlom J
Cancer Res; 1990 Feb; 50(4):1291-8. PubMed ID: 2297774
[TBL] [Abstract][Full Text] [Related]
30. Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma.
Torenbeek R; Lagendijk JH; Van Diest PJ; Bril H; van de Molengraft FJ; Meijer CJ
Histopathology; 1998 Jan; 32(1):20-7. PubMed ID: 9522212
[TBL] [Abstract][Full Text] [Related]
31. Tumor specificity of monoclonal antibodies to carcinoembryonic antigen. Immunohistochemical analysis.
Zoubir F; Zeromski J; Sikora J; Szmeja J; Hedin A; Hammarström S
Tumour Biol; 1990; 11(1-2):5-19. PubMed ID: 2408131
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical comparison of new monoclonal antibody 1C5 and carcinoembryonic antigen in the differential diagnosis of adenocarcinoma of the uterine cervix.
Kudo R; Sasano H; Koizumi M; Orenstein JM; Silverberg SG
Int J Gynecol Pathol; 1990; 9(4):325-36. PubMed ID: 1700970
[TBL] [Abstract][Full Text] [Related]
33. Monoclonal antibodies against CEA-related components discriminate between pancreatic duct type carcinomas and nonneoplastic duct lesions as well as nonduct type neoplasias.
Bätge B; Bosslet K; Sedlacek HH; Kern HF; Klöppel G
Virchows Arch A Pathol Anat Histopathol; 1986; 408(4):361-74. PubMed ID: 3004013
[TBL] [Abstract][Full Text] [Related]
34. Quality control of immunocytochemical staining of effusions using a standardized method of cell processing.
Kuenen-Boumeester V; van Loenen P; de Bruijn EM; Henzen-Logmans SC
Acta Cytol; 1996; 40(3):475-9. PubMed ID: 8669182
[TBL] [Abstract][Full Text] [Related]
35. Is immunostaining with HAM56 antibody useful in identifying ovarian origin of metastatic adenocarcinomas?
Cheung AN; Chiu PM; Khoo US
Hum Pathol; 1997 Jan; 28(1):91-4. PubMed ID: 9013838
[TBL] [Abstract][Full Text] [Related]
36. Metastatic adenocarcinoma of an unknown primary site. A comparison of the relative contributions of morphology, minimal essential clinical data and CEA immunostaining status.
Sheahan K; O'Keane JC; Abramowitz A; Carlson JA; Burke B; Gottlieb LS; O'Brien MJ
Am J Clin Pathol; 1993 Jun; 99(6):729-35. PubMed ID: 8322709
[TBL] [Abstract][Full Text] [Related]
37. Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas.
Ramaekers F; van Niekerk C; Poels L; Schaafsma E; Huijsmans A; Robben H; Schaart G; Vooijs P
Am J Pathol; 1990 Mar; 136(3):641-55. PubMed ID: 1690512
[TBL] [Abstract][Full Text] [Related]
38. Carcinoembryonic antigen isotypes in tissue sections and loose cyst fluid cells of ovarian neoplasms.
Harłozińska A; Bar JK; Jothy S; Sedlaczek P; Slesak B; Richter R
Tumour Biol; 1993; 14(1):1-8. PubMed ID: 7684152
[TBL] [Abstract][Full Text] [Related]
39. [Metastatic tumors in the ovary, difficulties of histologic diagnosis].
Tamás J; Vereczkey I; Tóth E
Magy Onkol; 2015 Sep; 59(3):205-13. PubMed ID: 26339910
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical analysis of pulmonary and pleural neoplasms using a monoclonal antibody (47D10) which reacts with nonspecific cross-reacting antigen.
Radosevich JA; Robinson PG; Carney WP; Warren W; Rosen ST; Gould VE
Tumour Biol; 1989; 10(6):281-8. PubMed ID: 2480629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]